Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial

被引:60
|
作者
Lubitz, Steven A. [1 ,2 ,5 ]
Atlas, Steven J. [3 ]
Ashburner, Jeffrey M. [3 ,5 ]
Lipsanopoulos, Ana T. Trisini [4 ]
Borowsky, Leila H. [3 ]
Guan, Wyliena [6 ]
Khurshid, Shaan [1 ,2 ,5 ]
Ellinor, Patrick T. [1 ,2 ,5 ]
Chang, Yuchiao [3 ,5 ]
McManus, David D. [7 ]
Singer, Daniel E. [3 ,5 ]
机构
[1] Massachusetts Gen Hosp, Cardiovasc Res Ctr, 55 Fruit St,GRB 109, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Demoulas Ctr Cardiac Arrhythmias, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Univ N Carolina, Chapel Hill, NC 27515 USA
[7] Univ Massachusetts, Med Sch, Dept Med, Worcester, MA USA
关键词
atrial fibrillation; digital health; electrocardiography; screening; ORAL ANTICOAGULATION; RISK-FACTOR; STROKE; THROMBOEMBOLISM; RATIONALE; DIAGNOSIS; DESIGN; DEVICE; ECG;
D O I
10.1161/CIRCULATIONAHA.121.057014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Undiagnosed atrial fibrillation (AF) may cause preventable strokes. Guidelines differ regarding AF screening recommendations. We tested whether point-of-care screening with a handheld single-lead ECG at primary care practice visits increases diagnoses of AF. METHODS: We randomized 16 primary care clinics 1:1 to AF screening using a handheld single-lead ECG (AliveCor KardiaMobile) during vital sign assessments, or usual care. Patients included were ages >= 65 years. Screening results were provided to primary care clinicians at the encounter. All confirmatory diagnostic testing and treatment decisions were made by the primary care clinician. New AF diagnoses during the 1-year follow-up were ascertained electronically and manually adjudicated. Proportions and incidence rates were calculated. Effect heterogeneity was assessed. RESULTS: Of 30 715 patients without prevalent AF (n=15 393 screening [91% screened], n=15 322 control), 1.72% of individuals in the screening group had new AF diagnosed at 1 year versus 1.59% in the control group (risk difference, 0.13% [95% CI, -0.16 to 0.42]; P=0.38). In prespecified subgroup analyses, new AF diagnoses in the screening and control groups were greater among those aged >= 85 years (5.56% versus 3.76%, respectively; risk difference, 1.80% [95% CI, 0.18 to 3.30]). The difference in newly diagnosed AF between the screening period and the previous year was marginally greater in the screening versus control group (0.32% versus -0.12%; risk difference, 0.43% [95% CI, -0.01 to 0.84]). The proportion of individuals with newly diagnosed AF who were initiated on oral anticoagulants was not different in the screening (n=194, 73.5%) and control (n=172, 70.8%) arms (risk difference, 2.7% [95% CI, -5.5 to 10.4]). CONCLUSIONS: Screening for AF using a single-lead ECG at primary care visits did not affect new AF diagnoses among all individuals aged 65 years or older compared with usual care.
引用
收藏
页码:946 / 954
页数:9
相关论文
共 50 条
  • [1] Screening for Atrial Fibrillation in Older Adults at Primary Care Visits Using Single Lead Electrocardiograms: The VITAL-AF Trial
    Lubitz, Steven A.
    Atlas, Steven
    Ashburner, Jeffrey M.
    Lipsanopoulos, Ana T.
    Borowsky, Leila H.
    Guan, Wyliena
    Khurshid, Shaan
    Ellinor, Patrick T.
    Chang, Yuchiao
    McManus, David D.
    Singer, Daniel E.
    CIRCULATION, 2020, 142 (24) : E491 - E491
  • [2] Targeted Atrial Fibrillation Screening in Older Adults: A Secondary Analysis of the VITAL-AF Trial
    Shah, Sachin
    Iyer, Jay
    Agha, Leila
    Chang, Yuchiao
    Atlas, Steven
    Ashburner, Jeffrey
    McManus, David
    Ellinor, Patrick
    Lubitz, Steven
    Singer, Daniel
    CIRCULATION, 2024, 150
  • [3] Design and rationale of a pragmatic trial integrating routine screening for atrial fibrillation at primary care visits: The VITAL-AF trial
    Ashburner, Jeffrey M.
    Atlas, Steven J.
    McManus, David D.
    Chang, Yuchiao
    Lipsanopoulos, Ana T. Trisini
    Borowsky, Leila H.
    Guan, Wyliena
    He, Wei
    Ellinor, Patrick T.
    Singer, Daniel E.
    Lubitz, Steven A.
    AMERICAN HEART JOURNAL, 2019, 215 : 147 - 156
  • [4] Frequency of Atrial Fibrillation in a Contemporary Elderly Primary Care Population: A Vital-af Trial Study
    Khurshid, Shaan
    Ashburner, Jeffrey M.
    Chang, Yuchiao
    Lipsanopoulos, Ana T. Trisini
    Borowsky, Leila H.
    Guan, Wyliena
    Ellinor, Patrick T.
    McManus, David D.
    Atlas, Steven
    Singer, Daniel
    Lubitz, Steven A.
    CIRCULATION, 2021, 144
  • [5] Screening for atrial fibrillation in older adults at primary care visits
    Estes, N. A. Mark, III
    HEART RHYTHM, 2022, 19 (06) : 1037 - 1037
  • [6] Screening for undiagnosed atrial fibrillation using a single-lead electrocardiogram at primary care visits: patient uptake and practitioner perspectives from the VITAL-AF trial
    Atlas, Steven J.
    Ashburner, Jeffrey M.
    Chang, Yuchiao
    Borowsky, Leila H.
    Ellinor, Patrick T.
    McManus, David D.
    Lubitz, Steven A.
    Singer, Daniel E.
    BMC PRIMARY CARE, 2023, 24 (01):
  • [7] Screening for undiagnosed atrial fibrillation using a single-lead electrocardiogram at primary care visits: patient uptake and practitioner perspectives from the VITAL-AF trial
    Steven J. Atlas
    Jeffrey M. Ashburner
    Yuchiao Chang
    Leila H. Borowsky
    Patrick T. Ellinor
    David D. McManus
    Steven A. Lubitz
    Daniel E. Singer
    BMC Primary Care, 24
  • [8] Oral Anticoagulant Therapy Following Single-Lead ECG Screening Among Older Patients With Atrial Fibrillation: The VITAL-AF Trial
    Ashburner, Jeffrey M.
    Singer, Daniel
    Chang, Yuchiao
    Khurshid, Shaan
    Lipsanopoulos, Ana
    Borowsky, Leila H.
    Ellinor, Patrick T.
    McManus, David D.
    Lubitz, Steven A.
    Atlas, Steven
    CIRCULATION, 2021, 144
  • [9] Accuracy and variability of cardiologist interpretation of single lead electrocardiograms for atrial fibrillation: The VITAL-AF trial
    Pipilas, Daniel C.
    Khurshid, Shaan
    Atlas, Steven J.
    Ashburner, Jeffrey M.
    Lipsanopoulos, Ana T.
    Borowsky, Leila H.
    Guan, Wyliena
    Ellinor, Patrick T.
    McManus, David D.
    Singer, Daniel E.
    Chang, Yuchiao
    Lubitz, Steven A.
    AMERICAN HEART JOURNAL, 2023, 265 : 92 - 103
  • [10] Abnormal Single-Lead Electrocardiograms Predict Future Atrial Fibrillation Risk: The VITAL-AF Trial
    Pipilas, Daniel
    Khurshid, Shaan
    Al-Alusi, Mostafa
    Atlas, Steven
    Ashburner, Jeffrey M.
    Borowsky, Leila H.
    McManus, David D.
    Singer, Daniel E.
    Lubitz, Steven A.
    Chang, Yuchiao
    Ellinor, Patrick T.
    CIRCULATION, 2023, 148